Open source drug discovery gets its day in the sun

10/24/2013 | Xconomy

Merck, Johnson & Johnson and Sanofi recently launched open source drug development projects that "represent a sea change in the pre-competitive landscape for pharmaceutical development," writes John Wilbanks, a senior fellow at FasterCures and chief commons officer at Sage Bionetworks. The open source movement in drug discovery is being driven by massive public investment in health and biology, as well as governmental and institutional momentum to open knowledge bases for reuse and recombination, Wilbanks writes. "This level of progress would have been unthinkable just a decade ago at the height of the first genomics bubble," he writes.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park